Daily oral edaravone (Radicava ORS) was not superior to the FDA-approved on/off regimen in amyotrophic lateral sclerosis (ALS ...

In one of the case reports, a 75-year-old White man with hereditary coagulopathy presented with myasthenic crisis in the setting of acute pulmonary embolism. Chronic symptoms included diplopia, ptosis ...

A first-in-class anti-CD19 B-cell depleting agent was safe and demonstrated superior efficacy vs placebo in patients with ...

For immediate release Nipocalimab demonstrates sustained disease control in adolescents living with generalised myasthenia ...

UCB will contribute 14 presentations, including an oral presentation, selected to feature across the AANEM and MGFA meeting, emphasizing UCB's leadership in neuromuscular researchPresentations ...

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced three presentations at the 2024 American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) Annual Meeting being held in ...

Johnson & Johnson (NYSE: JNJ) today announced positive results from the Phase 2/3 Vibrance-MG study of nipocalimab in anti-AChRa positive adolescents (aged 12 – 17 years) living with generalized ...

Brussels, Belgium Monday, October 14, 2024, 17:00 Hrs [IST] ...

For nearly a decade, Doug Wintemute has specialized in helping students and professionals make sound education and career decisions. In addition to Forbes Advisor, his work has been featured on ...

Presumably to be her manager. I regret nothing. Certainly not after watching the FX docuseries “Social Studies.” As schools reopened after the COVID-19 closures, filmmaker Lauren Greenfield ...

A study of nearly 400,000 scientists across 38 countries finds that one-third of them quit science within five years of authoring their first paper, and almost half leave within a decade.